PATTY COCKMAN: Open Payments
NPI 1598764417 · FAYETTEVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$755 in 35 payments from 15 companies in 2025. Trend: 2023 $862 · 2024 $883 · 2025 $755
Food & beverage: $755
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 5 | $126 |
| Fresenius USA Marketing, Inc. | 4 | $86 |
| Vifor Pharma, Inc. | 3 | $79 |
| Ardelyx, Inc. | 4 | $77 |
| ANI Pharmaceuticals, Inc. | 3 | $66 |
| Calliditas Therapeutics US Inc. | 2 | $55 |
| AstraZeneca Pharmaceuticals LP | 3 | $54 |
| Travere Therapeutics, Inc. | 2 | $38 |
| Lilly USA, LLC | 2 | $35 |
| Amgen Inc. | 2 | $34 |
Products named: JYNARQUE, VELPHORO, Veltassa, IBSRELA, PURIFIED CORTROPHIN GEL, TARPEYO, FARXIGA, JARDIANCE.
Industry payments across NC — which companies pay providers there.
